Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Vycor Medical (VYCO) Other Gross PP&E Adjustments (2016 - 2025)

Vycor Medical has reported Other Gross PP&E Adjustments over the past 15 years, most recently at $1.4 million for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 8.41% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, up 8.41% year-over-year, with the annual reading at $1.4 million for FY2025, 8.41% up from the prior year.
  • Other Gross PP&E Adjustments was $1.4 million for Q4 2025 at Vycor Medical, up from -$67615.0 in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $1.4 million in Q4 2025 and troughed at -$160979.0 in Q3 2023.
  • The 5-year median for Other Gross PP&E Adjustments is -$67834.0 (2022), against an average of $254359.0.
  • Year-over-year, Other Gross PP&E Adjustments surged 85.34% in 2023 and then crashed 1436.68% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $1.3 million in 2021, then grew by 5.24% to $1.3 million in 2022, then fell by 9.61% to $1.2 million in 2023, then grew by 4.34% to $1.2 million in 2024, then rose by 8.41% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Other Gross PP&E Adjustments are $1.4 million (Q4 2025), -$67615.0 (Q3 2025), and -$79793.0 (Q2 2025).